Notification

🚨 Trading Holiday 🚨

The NSE and BSE will remain closed for trading and settlement on Friday, April 18, 2025, on account of Good Friday.

Open a Free Demat Account

Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.

Trade Now, Pay Later with up to 4x

Never miss a good trading opportunity due to low funds with our MTF feature.

Track Market Movers Instantly

Stay updated with real-time data. Get insights at your fingertips.

NSE BSE

Trade Nowopens in a new tab

Citurgia Biochemicals Ltd. Share Price

₹ 158.2 0.00 (0.00%)

Jan 11 2013 12:00AM Chemicals NSE: CITURGIA

Citurgia Biochemicals Ltd. Share Price Update

As of the latest trading session, Citurgia Biochemicals Ltd. share price is currently at 158.2, which is up by 0.00 from its previous closing. Today, the stock has fluctuated between 150.00 and 158.95. Over the past year, Citurgia Biochemicals Ltd. has achieved a return of -24.66 %. In the last month alone, the return has been 9.10 %. Read More...

Citurgia Biochemicals Ltd. Performance

Day Range

Low150.00 High158.95

158.20

52 Week Range

Low .00 High 158.95

158.20

Citurgia Biochemicals Ltd. Share Price

506373

CITURGIA

Compare to down-arrow

View

Display

Studies

No Data Available

Open Price

152.00 Prev. Close

158.20 Volume (Shares)

50.00 Total traded value

.07

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Loginopens in a new tab to your account for live updates.

Citurgia Biochemicals Ltd. Fundamentals

(Standalone)

Market Cap (Cr)	0.0
PE Ratio (TTM)	0.0
Book Value / Share	0.0
Beta	0.0

ROE	0.0%
EPS (TTM)	0.0
Dividend Yield	0.0%
Net Profit Qtr (Cr)	0.0

Citurgia Biochemicals Ltd. Financials

Key Results
Key Ratios
Balance sheet
Cash Flow
Competition

Revenue

Net income

Particulars	DEC 2024 (Values in Cr)
Revenue	0.00
Operating Expense	0.10
Net Profit	-0.10
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	0.01
EBITDA	-0.04
Effective Tax Rate (%)	0.00

Particulars	SEP 2024 (Values in Cr)
Revenue	0.00
Operating Expense	0.14
Net Profit	-0.14
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.01
EBITDA	-0.08
Effective Tax Rate (%)	0.00

Particulars	JUN 2024 (Values in Cr)
Revenue	0.00
Operating Expense	0.09
Net Profit	-0.09
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.01
EBITDA	-0.03
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	0.00
Operating Expense	0.13
Net Profit	-0.13
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.01
EBITDA	-0.07
Effective Tax Rate (%)	0.00

Particulars	DEC 2023 (Values in Cr)
Revenue	0.00
Operating Expense	0.11
Net Profit	-0.11
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	0.01
EBITDA	-0.05
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Revenue	0.00
Operating Expense	0.48
Net Profit	-0.48
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.03
EBITDA	-0.24
Effective Tax Rate (%)	0.00

Particulars	MAR 2023 (Values in Cr)
Revenue	0.00
Operating Expense	0.44
Net Profit	-0.44
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.03
EBITDA	-0.21
Effective Tax Rate (%)	0.00

Particulars	MAR 2022 (Values in Cr)
Revenue	0.00
Operating Expense	0.40
Net Profit	-0.40
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.03
EBITDA	-0.17
Effective Tax Rate (%)	0.00

Particulars	MAR 2021 (Values in Cr)
Revenue	0.00
Operating Expense	0.61
Net Profit	-0.61
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.05
EBITDA	-0.37
Effective Tax Rate (%)	0.00

Particulars	MAR 2020 (Values in Cr)
Revenue	0.00
Operating Expense	0.40
Net Profit	-0.40
Net Profit Margin (%)	0.00
Earnings Per Share (EPS)	-0.15
EBITDA	-0.12
Effective Tax Rate (%)	0.00

Particulars	MAR 2024 (Values in Cr)
Book Value / Share	-3.43
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	0.00

Particulars	MAR 2023 (Values in Cr)
Book Value / Share	-3.25
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	0.00

Particulars	MAR 2022 (Values in Cr)
Book Value / Share	-3.09
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	0.00

Particulars	MAR 2021 (Values in Cr)
Book Value / Share	-2.93
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	0.00

Particulars	MAR 2020 (Values in Cr)
Book Value / Share	-2.70
ROE %	0.00
ROCE %	0.00
Total Debt to Total Equity	0.00
EBITDA Margin	0.00

Particulars	MAR 2024 (Values in Cr)
Cash & Short Term Investments	0.10
Total Assets	11.04
Total Liabilities	11.04
Total Equity	-6.56
Share Outstanding	26419063
Price to Book Ratio	0.00
Return on Assets (%)	-4.30
Return on Capital (%)	-236.53

Particulars	MAR 2023 (Values in Cr)
Cash & Short Term Investments	0.07
Total Assets	11.19
Total Liabilities	11.19
Total Equity	-6.09
Share Outstanding	26419063
Price to Book Ratio	0.00
Return on Assets (%)	-3.89
Return on Capital (%)	-95.11

Particulars	MAR 2022 (Values in Cr)
Cash & Short Term Investments	0.05
Total Assets	11.42
Total Liabilities	11.42
Total Equity	-5.65
Share Outstanding	26419063
Price to Book Ratio	0.00
Return on Assets (%)	-3.53
Return on Capital (%)	-48.18

Particulars	MAR 2021 (Values in Cr)
Cash & Short Term Investments	0.06
Total Assets	11.59
Total Liabilities	11.59
Total Equity	-5.25
Share Outstanding	26419063
Price to Book Ratio	0.00
Return on Assets (%)	-5.27
Return on Capital (%)	-49.23

Particulars	MAR 2020 (Values in Cr)
Cash & Short Term Investments	0.05
Total Assets	11.97
Total Liabilities	11.97
Total Equity	-4.64
Share Outstanding	26419063
Price to Book Ratio	0.00
Return on Assets (%)	-3.30
Return on Capital (%)	-21.5

Particulars	MAR 2024 (Values in Cr)
Net Income	-0.47
Cash from Operations	-0.14
Cash from Investing	-0.05
Cash from Financing	0.21
Net change in Cash	0.02
Free Cash Flow	-0.14

Particulars	MAR 2023 (Values in Cr)
Net Income	-0.43
Cash from Operations	-0.06
Cash from Investing	0.03
Cash from Financing	0.05
Net change in Cash	0.02
Free Cash Flow	-0.06

Particulars	MAR 2022 (Values in Cr)
Net Income	-0.40
Cash from Operations	-0.02
Cash from Investing	0.01
Cash from Financing	0.00
Net change in Cash	-0.01
Free Cash Flow	-0.02

Particulars	MAR 2021 (Values in Cr)
Net Income	-0.61
Cash from Operations	-0.14
Cash from Investing	0.14
Cash from Financing	0.01
Net change in Cash	0.00
Free Cash Flow	-0.14

Particulars	MAR 2020 (Values in Cr)
Net Income	-0.39
Cash from Operations	-0.11
Cash from Investing	0.05
Cash from Financing	0.00
Net change in Cash	-0.05
Free Cash Flow	-0.11

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ATUL LTD	5709.15	40.42	2.99	16808.74	4882.00 / 8165.25
BASF INDIA LTD	4530.05	32.50	5.58	19608.61	3535.80 / 8748.10
ORIENTAL AROMATICS LTD	310.60	24.30	1.59	1045.28	252.40 / 656.00
DEEPAK FERTILIZERS & PETR	1258.50	18.24	2.79	15887.03	500.85 / 1443.35
DEEPAK NITRITE LTD	1971.60	38.93	5.28	26891.25	1780.50 / 3168.65

Company Name	Price	P/E	P/B	Market Cap	52 Week Low/High
ADVANCE PETROCHEMICALS LTD.	188.80	64.66	4.63	16.99	168.50 / 330.00
ATUL LTD	5709.15	41.45	3.02	16808.74	4882.00 / 8165.25
BASF INDIA LTD	4530.05	32.49	5.58	19608.61	3535.80 / 8748.10
ORIENTAL AROMATICS LTD	310.60	21.39	1.58	1045.28	252.40 / 656.00

Technicals

EMA & SMA
Resistance and Support
Price Change Analysis

Bullish Moving Averages -

Bearish Moving Averages -

5 Days 0.00
26 Days 0.00
10 Days 0.00
50 Days 0.00
12 Days 0.00
100 Days 0.00
20 Days 0.00
200 Days 0.00

0.0
PIVOT

First Resistance	0.0
Second Resistance	0.0
Third Resistance	0.0

First Support	0.0
Second Support	0.0
Third Support	0.0

RSI	0.0
MACD	0.0
Commodity Channel Index (CCI)	0.0

ADX	0.0
Williams % R	0.0

Citurgia Biochemicals Ltd. Future

Future: Price

25 May

0 100 200 300 400 500 600

Discount/Premium

25 May

0 1 2 3 4 5 6 7

Active Calls

25 May

0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul

0 500 1000 1500 2000 2500

Stock Holding

View Live Stock Screeners

Holding

Public

0.32 Promoter Holdings

99.67 FII

0.0 DII

0.0 Promoter Shares(Pledge Percentage)

0.0

Name	Category	Shares	Shares%
Satya Sheel Engineers And Miners Private Limited	Shareholding of Promoter and Promoter Group	8.01E7	60.64
Dev Versha Jetro Valley Private Limited	Shareholding of Promoter and Promoter Group	3.585E7	27.14
Gandharva Holding Limited	Shareholding of Promoter and Promoter Group	7650000.0	5.79
Gem Info Solutions Private Limited	Shareholding of Promoter and Promoter Group	7600000.0	5.75
The Bombay Dyeing And Manufacturing Company Limited	Shareholding of Promoter and Promoter Group	77800.0	0.06
Nowrosjee Wadia And Sons Limited	Shareholding of Promoter and Promoter Group	78265.0	0.06
Jehreen Investments Limited	Shareholding of Promoter and Promoter Group	65735.0	0.05
Lochness Investments Limited	Shareholding of Promoter and Promoter Group	65735.0	0.05
Nusli Neville Wadia	Shareholding of Promoter and Promoter Group	54050.0	0.04
Elite Capital & Management Services Limited	Shareholding of Promoter and Promoter Group	50000.0	0.04
Nessville Trading Ltd	Shareholding of Promoter and Promoter Group	20560.0	0.02
The Bombay Burmah Trdg Corp. Ltd	Shareholding of Promoter and Promoter Group	23520.0	0.02
N W Exports Limited	Shareholding of Promoter and Promoter Group	17495.0	0.01
Macrofil Investments Limited	Shareholding of Promoter and Promoter Group	3835.0	0.0
Sunflower Investments And Textiles Private Limited	Shareholding of Promoter and Promoter Group	5850.0	0.0
Ness N Wadia	Shareholding of Promoter and Promoter Group	5.0	0.0
Jehangir N Wadia	Shareholding of Promoter and Promoter Group	5.0	0.0
Maureen N Wadia	Shareholding of Promoter and Promoter Group	510.0	0.0
Dina Neville Wadia	Shareholding of Promoter and Promoter Group	1880.0	0.0

Citurgia Biochemicals Ltd.

Ex-Date	Dividend Amt.	Dividend Type	Record Date	Instrument Type

Ex-Date	Old FV	NEW FV	Record Date
2018-04-26	10.0	2.0	2018-04-30

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

Zydus Lifesciences’ VC arm Zynext Ventures invests in Canada’s Feldan Therapeutics to advance innovation in intracellular drug delivery technologies.

17 Apr, 2025 | 3 Min. read

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

DLF Ltd to sell its 25.9-acre Kolkata IT SEZ, including DLF Tech Park, to Srijan Group for Rs.693 crore through a slump sale.

17 Apr, 2025 | 3 Min. read

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

UltraTech Cement to invest Rs.25.5 crore for a 26% stake in AMPIN C&I Power Eight to secure green energy for operations and reduce power costs.

17 Apr, 2025 | 3 Min. read

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

BHEL partners with BARC to adopt indigenous diaphragm technology for electrolysers, aiming to cut green hydrogen costs and reduce import dependency.

17 Apr, 2025 | 2 Min. read

CCI Approves Aster DM–Quality Care Merger; New Entity Named Aster DM Quality Care

CCI clears merger of Aster DM Healthcare and Quality Care India Ltd, forming Aster DM Quality Care Ltd. Combined entity to operate 38 hospitals with 10,150 beds.

16 Apr, 2025 | 3 Min. read

ICICI Lombard Q4 Profit Falls 1.9%, Declares ₹7 Final Dividend

ICICI Lombard Q4 net profit declines by 1.9% YoY to ₹509.6 crore, while FY25 PAT jumps 30.7%. Board declares ₹7 final dividend, total ₹12.5 for FY25.

16 Apr, 2025 | 3 Min. read

IndusInd Bank Finds ₹1,979 Crore Net Worth Hit in Derivatives Audit

An external audit reveals ₹1,979 crore impact on IndusInd Bank’s net worth due to derivative discrepancies. Bank to reflect changes in FY25 financial reports.

16 Apr, 2025 | 2 Min. read

Oil India Wins 9 Blocks in OALP Round-IX, Acreage Jumps 85%

Oil India secures 9 exploration blocks in OALP Round-IX, expanding its acreage by 85% to 1.10 lakh sq km. ONGC, Cairn, and BP also win key bids.

16 Apr, 2025 | 3 Min. read

Dr Reddy’s Denies Workforce Reduction Claims Amid Cost-Cut Rumours

Dr Reddy’s Laboratories rejects claims of reducing workforce costs by 25%, asserting no such plans or internal directives.

15 Apr, 2025 | 3 Min. read

Glenmark, Sun Pharma, Zydus Recall Drugs in US over Compliance Issues

Glenmark, Sun Pharma, and Zydus recall multiple drug batches in the US following manufacturing deviations and contamination concerns as per USFDA enforcement reports.

15 Apr, 2025 | 3 Min. read

About Citurgia Biochemicals Ltd.

Companies Owned by Citurgia Biochemicals Ltd.

We have something for everyone

Explore More Investment Options

Start Investing

Stocks

Secure and enhance your financial future today

Invest

IPOs

Your gateway to future financial opportunities

Invest

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x

Invest

US Stocks

Discover opportunities to invest in elite FAANG stocks

Invest

Frequently Asked Questions

What is the Share Price of Citurgia Biochemicals Ltd?

Answer Field: The share price of Citurgia Biochemicals Ltd for NSE is ₹ 18.00 and for BSE is ₹ 158.20.

What is the Market Cap of Citurgia Biochemicals Ltd?

Answer Field: The market cap of Citurgia Biochemicals Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Citurgia Biochemicals Ltd?

Answer Field: The 52 Week High and Low of Citurgia Biochemicals Ltd for NSE is ₹ 18.75 and ₹ 0.00 and for BSE is ₹ 158.95 and ₹ 0.00.

How to Buy Citurgia Biochemicals Ltd share?

Answer Field: You can trade in Citurgia Biochemicals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Citurgia Biochemicals Ltd?

Answer Field: The 1 year returns on the stock has been -24.66%.

What is the Current Share Price of Citurgia Biochemicals Ltd?

Answer Field: Citurgia Biochemicals Ltd share price is for NSE ₹ 18.00 & for BSE ₹ 158.20 as on Jan 11 2013 12:00AM.

What is the Market Cap of Citurgia Biochemicals Ltd Share?

Answer Field: The market cap of Citurgia Biochemicals Ltd for NSE ₹ 0.0 & for BSE ₹ 0.0 as on Jan 11 2013 12:00AM.

What is the P/E Ratio of Citurgia Biochemicals Ltd Share?

Answer Field: As on Jan 11 2013 12:00AM the price-to-earnings (PE) ratio for Citurgia Biochemicals Ltd share is 0.0.

What is the PB ratio of Citurgia Biochemicals Ltd Share?

Answer Field: As on Jan 11 2013 12:00AM, the price-to-book (PB) ratio for Citurgia Biochemicals Ltd share is 0.0.

How to Buy Citurgia Biochemicals Ltd Share?

Answer Field: You can trade in Citurgia Biochemicals Ltd shares with Bajaj Broking by opening a demat accountopens in a new tab.

How to Buy Citurgia Biochemicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Citurgia Biochemicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Citurgia Biochemicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Scan to download

Download from App Store

Download from Play Store

9.5 lakh+ Users

4+ App Rating

4 Languages

₹4400+ Cr MTF Book

Open Demat Account

🚨 Trading Holiday 🚨

Open a Free Demat Account

Trade Now, Pay Later with up to 4x

Track Market Movers Instantly

Citurgia Biochemicals Ltd. Share Price

Citurgia Biochemicals Ltd. Share Price Update

Citurgia Biochemicals Ltd. Performance

Day Range

52 Week Range

Citurgia Biochemicals Ltd. Share Price

Open Price

152.00

Prev. Close

158.20

Volume (Shares)

50.00

Total traded value

.07

Upper Circuit

.00

Lower Circuit

.00

Citurgia Biochemicals Ltd. Fundamentals

Citurgia Biochemicals Ltd. Financials

Revenue

Net income

Technicals

Over 1 Month

9.10

Over 3 Months

-1.52

Over 6 Months

12.43

Over 1 Year

-24.66

Over 3 Years

-11.84

Over 5 Years

0.00

Citurgia Biochemicals Ltd. Future

Future: Price

Discount/Premium

Active Calls

Active Puts

Citurgia Biochemicals Ltd. Shareholding Pattern

Stock Holding

View Live Stock Screeners

Holding

Public

0.32

Promoter Holdings

99.67

FII

0.0

DII

0.0

Promoter Shares(Pledge Percentage)

0.0

Holding %

Pledges % of promoter shares %

MF Holding %

FII Holding %

Citurgia Biochemicals Ltd.

Learn More About Stocks

Zydus Lifesciences Invests in Feldan to Boost Drug Delivery Innovation

DLF To Sell Kolkata IT SEZ To Srijan Group For Rs.693 Crore

UltraTech Cement Acquires 26% Stake in Solar SPV for Rs.25.5 Crore

BHEL Signs Tech Deal With BARC to Cut Green Hydrogen Costs

About Citurgia Biochemicals Ltd.

Companies Owned by Citurgia Biochemicals Ltd.

Explore More Investment Options

Stocks

IPOs

MTF

US Stocks

Frequently Asked Questions

What is the Share Price of Citurgia Biochemicals Ltd?

What is the Market Cap of Citurgia Biochemicals Ltd?

What is the 52 Week High and Low of Citurgia Biochemicals Ltd?

How to Buy Citurgia Biochemicals Ltd share?